NCT07153705尚未招募不适用
OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer
Beihua Kong0 个研究点目标入组 32 人开始时间: 2025年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 32
- 主要终点
- OCS product inspection
研究概览
简要总结
To study the performance of OCS products based on exosome detection technology in monitoring the recurrence of baseline CA125-negative ovarian cancer patients after initial treatment, and to explore reliable methods for monitoring the recurrence of baseline CA125-negative ovarian cancer patients after initial treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
OCS product inspection
时间窗: Before the operation
次要结局
未报告次要终点
研究者
Beihua Kong
archiater
Shandong University
相似试验
已完成
不适用
Non-Invasive, Highly Specific Detection of Oxytocin in Biological FluidsOxytocinPregnancyNCT03140709Stanford University28
招募中
不适用
The development of exosome monitoring marker in pancreatic cancerjRCT1030230227Senya Matsufuji280
已完成
不适用
Evaluation of esCCO monitoring for continuous, non-invasive measurement of cardiac outputQ05.9I50.9Spina bifida, unspecifiedHeart failure, unspecifiedDRKS00008769niversitätsklinikum GießenAbteilung für Anästhesiologie, Operative Intensivmedizin und Schmerztherapie35
招募中
不适用
ExosoMe as Integrative Tool for pRognostic Stratification of Adverse Cardiac remodeLing in stEmi Patients: the MIRACLE StudySTEMINCT06070974Centro Cardiologico Monzino100
已完成
不适用
Comparison of the Ability of the esCCO and the Volume View to Measure Trends in Cardiac Output During Cardiac SurgeryCardiac Output, LowAnesthesiaNCT02964663Université Libre de Bruxelles19